CN1199968C - 新的地洛他定盐、其合成方法及其药物组合物 - Google Patents
新的地洛他定盐、其合成方法及其药物组合物 Download PDFInfo
- Publication number
- CN1199968C CN1199968C CNB018193382A CN01819338A CN1199968C CN 1199968 C CN1199968 C CN 1199968C CN B018193382 A CNB018193382 A CN B018193382A CN 01819338 A CN01819338 A CN 01819338A CN 1199968 C CN1199968 C CN 1199968C
- Authority
- CN
- China
- Prior art keywords
- formula
- desloratadine
- acid
- loratadine
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0004701A HU226998B1 (en) | 2000-11-23 | 2000-11-23 | Desloratadine hemisulphate, process for the preparation thereof and pharmaceutical compositions containing the same |
| HUP0004701 | 2000-11-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1476443A CN1476443A (zh) | 2004-02-18 |
| CN1199968C true CN1199968C (zh) | 2005-05-04 |
Family
ID=89978790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB018193382A Expired - Lifetime CN1199968C (zh) | 2000-11-23 | 2001-11-14 | 新的地洛他定盐、其合成方法及其药物组合物 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7196195B2 (enExample) |
| EP (1) | EP1347965B1 (enExample) |
| JP (1) | JP4427249B2 (enExample) |
| CN (1) | CN1199968C (enExample) |
| AT (1) | ATE316525T1 (enExample) |
| AU (1) | AU2002218422A1 (enExample) |
| CA (1) | CA2425422C (enExample) |
| CY (1) | CY1105595T1 (enExample) |
| CZ (1) | CZ304694B6 (enExample) |
| DE (1) | DE60116902T2 (enExample) |
| DK (1) | DK1347965T3 (enExample) |
| ES (1) | ES2257467T3 (enExample) |
| HU (1) | HU226998B1 (enExample) |
| NO (1) | NO325155B1 (enExample) |
| PL (1) | PL206973B1 (enExample) |
| RU (1) | RU2285001C2 (enExample) |
| SK (1) | SK285715B6 (enExample) |
| UA (1) | UA74858C2 (enExample) |
| WO (1) | WO2002042290A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003086275A2 (en) * | 2002-04-15 | 2003-10-23 | Sun Pharmaceutical Industries Limited | Preperation of desloratatine |
| HRP20050110A2 (en) * | 2002-08-05 | 2006-02-28 | Sandoz Ag | Novel salt and polymorphs of desloratadine hemifumarate |
| JP4501015B2 (ja) | 2004-03-17 | 2010-07-14 | 味の素株式会社 | アミノピリミジン化合物の製造方法 |
| EA011894B1 (ru) * | 2004-07-07 | 2009-06-30 | Эгиш Дьёдьсердьяр Нирт. | Новая псевдополиморфная форма деслоратадина, образованная с диоксидом углерода |
| CA2541045A1 (en) * | 2006-03-24 | 2007-09-24 | Pharmascience Inc. | A descarbonylethoxyloratadine containing pharmaceutical composition |
| EP2837631A1 (en) * | 2013-08-14 | 2015-02-18 | Merck & Cie | New stable salt of 5,10-methylene-(6R)-tetrahydrofolic acid |
| AU2020372682A1 (en) * | 2019-10-31 | 2022-06-09 | Jd Bioscience Inc. | Tricyclic compound and pharmaceutical use thereof |
| CN115785065A (zh) * | 2022-12-02 | 2023-03-14 | 山东达因海洋生物制药股份有限公司 | 一种地氯雷他定共晶及其制备方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4282233B1 (en) * | 1980-06-19 | 2000-09-05 | Schering Corp | Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines |
| WO1985003707A1 (en) * | 1984-02-15 | 1985-08-29 | Schering Corporation | 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
| EP0208855B1 (en) * | 1985-05-13 | 1991-03-06 | Schering Corporation | process for preparing piperidylidene dihydrodibenzo(a,d)cycloheptenes and aza derivatives thereof, compounds obtained by such process and the use of such compounds for preparing useful pharmaceutical compositions |
| PT656348E (pt) * | 1993-12-03 | 2000-10-31 | Hoffmann La Roche | Derivados do acido acetico como medicamentos |
| GB9709945D0 (en) * | 1997-05-17 | 1997-07-09 | Glaxo Group Ltd | A novel salt |
| SK287105B6 (sk) * | 1999-12-20 | 2009-12-07 | Schering Corporation | Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním |
| RU2164796C1 (ru) * | 2000-05-25 | 2001-04-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" | Противогистаминное средство и способ его получения |
-
2000
- 2000-11-23 HU HU0004701A patent/HU226998B1/hu unknown
-
2001
- 2001-11-14 AU AU2002218422A patent/AU2002218422A1/en not_active Abandoned
- 2001-11-14 WO PCT/HU2001/000111 patent/WO2002042290A1/en not_active Ceased
- 2001-11-14 US US10/432,387 patent/US7196195B2/en not_active Expired - Lifetime
- 2001-11-14 CZ CZ2003-1321A patent/CZ304694B6/cs unknown
- 2001-11-14 DK DK01997485T patent/DK1347965T3/da active
- 2001-11-14 RU RU2003118425/04A patent/RU2285001C2/ru active
- 2001-11-14 UA UA2003065756A patent/UA74858C2/uk unknown
- 2001-11-14 DE DE60116902T patent/DE60116902T2/de not_active Expired - Lifetime
- 2001-11-14 CA CA002425422A patent/CA2425422C/en not_active Expired - Lifetime
- 2001-11-14 CN CNB018193382A patent/CN1199968C/zh not_active Expired - Lifetime
- 2001-11-14 AT AT01997485T patent/ATE316525T1/de active
- 2001-11-14 EP EP01997485A patent/EP1347965B1/en not_active Expired - Lifetime
- 2001-11-14 SK SK566-2003A patent/SK285715B6/sk not_active IP Right Cessation
- 2001-11-14 ES ES01997485T patent/ES2257467T3/es not_active Expired - Lifetime
- 2001-11-14 JP JP2002544424A patent/JP4427249B2/ja not_active Expired - Lifetime
- 2001-11-14 PL PL362126A patent/PL206973B1/pl unknown
-
2003
- 2003-05-22 NO NO20032314A patent/NO325155B1/no not_active IP Right Cessation
-
2006
- 2006-03-29 CY CY20061100435T patent/CY1105595T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002218422A1 (en) | 2002-06-03 |
| HUP0004701A2 (hu) | 2002-11-28 |
| DE60116902D1 (de) | 2006-04-13 |
| PL206973B1 (pl) | 2010-10-29 |
| NO20032314L (no) | 2003-07-18 |
| HU0004701D0 (enExample) | 2001-02-28 |
| JP2004514675A (ja) | 2004-05-20 |
| ES2257467T3 (es) | 2006-08-01 |
| CZ304694B6 (cs) | 2014-09-03 |
| US20050203116A1 (en) | 2005-09-15 |
| PL362126A1 (en) | 2004-10-18 |
| JP4427249B2 (ja) | 2010-03-03 |
| CA2425422A1 (en) | 2002-05-30 |
| SK285715B6 (sk) | 2007-06-07 |
| CZ20031321A3 (cs) | 2003-08-13 |
| CN1476443A (zh) | 2004-02-18 |
| SK5662003A3 (en) | 2003-10-07 |
| DE60116902T2 (de) | 2006-08-24 |
| NO325155B1 (no) | 2008-02-11 |
| DK1347965T3 (da) | 2006-06-06 |
| US7196195B2 (en) | 2007-03-27 |
| CA2425422C (en) | 2009-11-10 |
| EP1347965B1 (en) | 2006-01-25 |
| UA74858C2 (en) | 2006-02-15 |
| EP1347965A1 (en) | 2003-10-01 |
| HU226998B1 (en) | 2010-04-28 |
| NO20032314D0 (no) | 2003-05-22 |
| RU2285001C2 (ru) | 2006-10-10 |
| CY1105595T1 (el) | 2010-07-28 |
| WO2002042290A1 (en) | 2002-05-30 |
| ATE316525T1 (de) | 2006-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5064024B2 (ja) | イマチニブの製造方法、及び該方法により製造されたイマチニブ | |
| CN1052005C (zh) | 咪唑并吡啶、其制法和药用 | |
| KR101539561B1 (ko) | 목시플록사신 염산염의 합성방법 | |
| CN1101385C (zh) | 取代的苯并咪唑衍生物及其制法和药物用途 | |
| KR20110064545A (ko) | 일라프라졸의 결정형 a, b의 제조방법 및 이들 결정형의 변환방법 | |
| CN1199968C (zh) | 新的地洛他定盐、其合成方法及其药物组合物 | |
| JP6215399B2 (ja) | ナルトレキソンの製造方法 | |
| WO1992017473A1 (en) | Crystalline tiagabine hydrochloride monohydrate, its preparation and use | |
| KR101827444B1 (ko) | 트리사이클로 유도체 화합물의 신규한 결정형 산부가염 또는 이의 수화물 및 이의 제조방법 | |
| US10351574B2 (en) | Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same | |
| KR100571944B1 (ko) | 결정형의 오사네탄트 | |
| JPH0374230B2 (enExample) | ||
| JP2010043053A (ja) | 高純度のレバミピドの製造方法 | |
| US20060025444A1 (en) | Fexofenadine base polymorphic forms | |
| CN1489578A (zh) | 3-(3-脒苯基)-5-[({[1-(1-亚氨基乙基)-4-哌啶基]甲基}氨基)甲基]苯甲酸二盐酸盐及其制备方法 | |
| AU627609B2 (en) | New quinoline derivatives and process for the preparation thereof | |
| EP0435995A1 (en) | New quinoline derivatives and process for the preparation thereof | |
| CN1240431A (zh) | N-[2-(二甲氨基)乙基]吖啶-4-甲酰胺的制备方法 | |
| BR112020003557A2 (pt) | composto de triaminopirimidina, forma cristalina, processo para a preparação do composto e composição | |
| HK1056731A (en) | Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20050504 |